Detalhe da pesquisa
1.
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.
Clin Gastroenterol Hepatol;
2019 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30625408
2.
Characterization of megapouch in patients with restorative proctocolectomy.
Surg Endosc;
2018 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30327916
3.
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol;
2018 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30268561